These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 722483)

  • 21. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM; Thurmond MS; Wenger J; Wenger NK
    J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
    Blanckaert D; Farriaux JP
    Nouv Presse Med; 1976 Mar; 5(11):713-4. PubMed ID: 772596
    [No Abstract]   [Full Text] [Related]  

  • 23. Colesevelam hydrochloride.
    Steinmetz KL
    Am J Health Syst Pharm; 2002 May; 59(10):932-9. PubMed ID: 12040732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding of bile acids to anion-exchanging drugs in vitro.
    Thale M; Faergeman O
    Scand J Gastroenterol; 1978; 13(3):353-6. PubMed ID: 755279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of colestipol and cholestyramine on the systemic clearance of intravenous ibuprofen in rabbits.
    el-Sayed YM; al-Meshal MA; al-Angary AA; Lutfi KM; Gouda MW
    J Pharm Pharmacol; 1994 Jan; 46(1):73-5. PubMed ID: 8201531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
    Ryzhenkov VE; Chistiakova AM; Triufanov VF; Vasil'eva LE; Frolova IuV; Solov'eva MA; Remezova OV; Lozovskiĭ VT; Khanefel'd M; Leonkhardt V
    Kardiologiia; 1990 Aug; 30(8):77-9. PubMed ID: 2255152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resins in the treatment of hypercholesterolemia].
    Jacotot B
    Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
    Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
    Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
    Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cholestyramine resin in the treatment of digitoxin toxicity.
    Cady WJ; Rehder TL; Campbell J
    Am J Hosp Pharm; 1979 Jan; 36(1):92-4. PubMed ID: 758792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypercholesterinemia: treatment with Colestyramin].
    Weizel A
    Fortschr Med; 1972 Jun; 90(18):715-8. PubMed ID: 5082079
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    Kinosian BP; Eisenberg JM
    JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing the in vitro bile acid binding capacity of diethylaminoethylcellulose by quaternization.
    Clas SD
    J Pharm Sci; 1991 Sep; 80(9):891-4. PubMed ID: 1800715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
    Garg A; Grundy SM
    Ann Intern Med; 1994 Sep; 121(6):416-22. PubMed ID: 8053615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypercholesteremia with cholestyramine, a bile acid sequestering resin.
    Casdorph HR
    Vasc Dis; 1967 Oct; 4(5):305-8. PubMed ID: 6051118
    [No Abstract]   [Full Text] [Related]  

  • 40. New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.
    McKenney JM
    Am Pharm; 1993 Jul; NS33(7):24-32. PubMed ID: 8342492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.